GlaxoSmithKline Egypt profit rises 22.5% y/y to $4.07mn in 2025

By bna Cairo bureau March 13, 2026

Pharmaceutical manufacturer GlaxoSmithKline (GSK) Egypt (EGX: BIOC) reported a 22.5% y/y increase in net profit during 2025, reaching EGP 213.2mn ($4.07mn), compared with EGP 174mn in 2024, according ...


This content is only available to Intellinews Pro users.

If you a Pro users click to login or request a trial.


Thank You,
bne IntelliNews Team

Dismiss
liveChat() ?>